Zhen Jiang Zhang

WEBSITE(S)| Cancer Trailblazers

Research Areas

Dr. Zhang's work focuses on developing nanomaterials for the delivery of a wide variety of drugs to metastatic cancer cells in the circulation. One such therapeutic Jason interfaces with is Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL), and he works to package soluble TRAIL in a variety of nano carriers as well as work on fusogenic liposomes with TRAIL as the delivered drug to avoid endocytosis and endosomal encapsulation.

Body

Profile updates sync daily at 5:15 a.m., 10:15 a.m., 1:15 p.m., 4:15 p.m., and 7:15 p.m. (CST)
Updates typically appear about 15 minutes after the next scheduled sync.

To update your profile:
Contact your website administrator or submit a request using our online form.